SERIES B WARRANT TO PURCHASE SHARES OF COMMON STOCK OF IMMUNOME, INC.Warrant Agreement • April 26th, 2021 • Immunome Inc. • Pharmaceutical preparations • New York
This Series B Warrant (the “Warrant”) is issued by Immunome, Inc., a Delaware corporation (the “Company”), to [________] (including any successors or assigns, the “Holder”), and is subject to the terms and conditions set forth below. The Warrant is being issued pursuant to a Warrant Agreement between the Company and American Stock Transfer & Trust Company, LLC (the “Warrant Agent”). Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement dated as of [__], 2021, among the Company and the purchasers signatory thereto (the “Purchase Agreement”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 26th, 2021 • Immunome Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 26, 2021 (the “Effective Date”), among Immunome, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).
